Converging Signals Synergistically Activate the LAMC2 Promoter and Lead to Accumulation of the Laminin Gamma 2 Chain in Human Colon Carcinoma Cells
Overview
Authors
Affiliations
The trimeric extracellular matrix molecule laminin-5 and its constituent chains (alpha 3, beta 3, gamma 2) are normally not detectable intracellularly in intestinal epithelial cells but the laminin gamma 2 chain can be detected in cancer cells at the invasive front of a subset of colon carcinomas. These cells are subjected to cytokines such as transforming growth factor beta 1 (TGF-beta 1) and hepatocyte growth factor (HGF), produced by the tumour cells or by the surrounding stromal cells. The purpose of the present work was to investigate whether TGF-beta 1 and HGF, known to stimulate the LAMC2 gene encoding the laminin gamma 2 chain, might synergize to activate the LAMC2 promoter, and to identify the promoter elements involved. We find evidence for synergy between TGF-beta and HGF with respect to laminin gamma 2 chain expression and promoter activation and demonstrate that this requires the 5' activator protein-1 (AP-1) element of the promoter and an additional upstream element which is also responsive to co-expression of the Smad3 protein from the TGF-beta signalling pathway. The transcripts encoding the other laminin-5 chains are not synergistically activated by HGF and TGF-beta. Thus the synergistic activation of the LAMC2 gene is mediated via different cis-elements and results in an overproduction of the laminin gamma 2 chain relative to the other laminin-5 constituent chains. This difference may explain why laminin gamma 2 chains accumulate in the cells at the invasive front of colon carcinomas.
Mattern S, Hollfoth V, Bag E, Ali A, Riemenschneider P, Jarboui M EMBO Mol Med. 2025; 17(3):441-468.
PMID: 39901020 PMC: 11903792. DOI: 10.1038/s44321-025-00194-7.
Liu J, Wang M, Wang M, Wang F, Zhang B Biochem Genet. 2023; 62(1):485-503.
PMID: 37382751 DOI: 10.1007/s10528-023-10435-4.
Anti-Laminin 332-Type Mucous Membrane Pemphigoid.
Shi L, Li X, Qian H Biomolecules. 2022; 12(10).
PMID: 36291670 PMC: 9599625. DOI: 10.3390/biom12101461.
Svec J, Stastna M, Janeckova L, Hrckulak D, Vojtechova M, Onhajzer J Cancers (Basel). 2022; 14(17).
PMID: 36077674 PMC: 9454662. DOI: 10.3390/cancers14174137.
Zhu Z, Song J, Guo Y, Huang Z, Chen X, Dang X Oncogene. 2020; 39(24):4666-4680.
PMID: 32398865 DOI: 10.1038/s41388-020-1321-5.